시장보고서
상품코드
1429404

세계 안구건조증 치료제 시장 보고서(2024년)

Dry Eye Medication Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

안구건조증 치료제 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상됩니다. 2028년 복합 연간 성장률(CAGR) 11.6%를 나타낼 전망이며 169억 3,000만 달러로 성장할 것으로 예상됩니다. 향후 성장이 예상되는 요인으로는 레이저 수술의 보급률 증가, 스크린 타임 증가, 바쁜 라이프 스타일, 당뇨병의 부담 증가, 안구건조증의 유병률의 상승, 안구건조증의 유망한 파이프라인, 질병 및 기타 약물과 관련된 부작용 등을 고려할 수 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 방부제가 없는 점안약 개발, 신약 및 선진약 연구개발 투자, 시장 경쟁력 유지를 위한 의약품 혁신, 비스테로이드 항염증성 안과제의 개발, 안구건조증 치료제, 최신 기술의 통합에 초점을 맞춘 연구, 안구건조증 치료를 위한 병용요법 개발 등이 포함됩니다.

안구건조증의 발생률이 증가함에 따라 치료에 대한 수요가 증가하고 있습니다. 노화, 비타민 A 결핍증, 콘택트렌즈 사용, 눈 수술, 건조한 바람과 연기 노출, 장시간 화면 시청 등의 요인이 안구건조증를 일으키기 쉬워지는 요인으로 확인되었습니다. 예를 들어, 미국 안과학회의 조사에서는 미국에서는 50세 이상의 여성 약 320만명, 남성 약 168만명이 안구건조증 증후군을 앓고 있는 것이 밝혀졌습니다. 마찬가지로 인도 안과 저널의 연구는 인도 북부의 안구건조증의 유병률이 32%인 것으로 나타났습니다. 이 질병의 유병률이 확대됨에 따라 치료에 대한 수요가 증가하여 안구건조증 치료제 시장의 성장이 촉진 될 것으로 예상됩니다.

안과 수술 건수 증가에 의해 안구건조증 치료제 시장의 확대가 촉진될 것으로 예상됩니다. 다양한 눈 상태와 질병의 진단, 치료 및 수술 관리에 중점을 둔 안과 수술은 눈 표면이 부드럽고 편안한 상태를 유지하기 위해 안구 건조 치료가 필요합니다. 이렇게 하면 수술이 더욱 원활해지고 수술 후 회복이 촉진됩니다. 예를 들어 2023년 10월 경제협력개발기구는 체코공화국에서 백내장 수술 건수가 8.4% 증가했으며 2021년 13만 1,612건에 비해 2022년 총 14만 2,670건이 되었습니다고 보고했습니다. 따라서 안과 수술 건수는 증가하는 경향이 있습니다. 안구건조증 치료제 시장의 성장의 원동력이되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고 인플레이션이 시장에 미치는 영향
  • 우크라이나,러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계 시장 규모 실적과 성장(2018년-2023년)
  • 세계 시장 규모 예측과 성장(2023년-2028년, 2033년)

제6장 시장 세분화

  • 세계 안구건조증 치료제 시장 : 제품 유형별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 수성
  • 증발성
  • 수성 및 증발성
  • 세계 안구건조증 치료제 시장 : 딜리버리 시스템별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 액체
  • 연고
  • 기타 딜리버리 시스템
  • 세계 안구건조증 치료제 시장 : 처방전 유형별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 일반용 의약품
  • 처방약
  • 세계 안구건조증 치료제 시장 : 최종 사용자별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 병원 약국
  • 안과 클리닉
  • 소매 약국
  • 온라인 약국

제7장 지역 및 국가 분석

  • 세계 안구건조증 치료제 시장 : 지역별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 세계 안구건조증 치료제 시장 : 국가별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 안구건조증 치료제 시장 경쟁 구도
  • 안구건조증 치료제 시장 기업 프로파일
    • Allergan plc
    • Alcon Inc.
    • Bausch Health Companies Inc.
    • Novartis AG
    • Otsuka Holdings Co. Ltd.

제31장 기타 선도적이고 혁신적인 기업

  • Santen Pharmaceutical Co., Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • OASIS Medical, Inc.
  • VISUfarma BV
  • Sun Pharmaceutical Industries Limited
  • Bayer AG
  • Pfizer
  • Johnson &Johnson
  • Daiichi Sankyo
  • Zhaoke Ophthalmology Pharmaceutical
  • Shanghai Pharmaceutical
  • ERC Labs
  • Vision gain
  • Medicom Health care
  • Implandata ophthalmic products GmbH

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 미래 전망과 가능성 분석

제36장 부록

BJH 24.03.21

Dry eye medication refers to drugs or medications used to address dry eye conditions by enhancing eye moisture. Dry eye is a multifactorial condition affecting the tears and ocular surface, leading to symptoms such as pain, blurred vision, tear film instability, and the potential for ocular surface injury.

The primary categories of dry eye medication include aqueous dry eye syndrome and evaporative dry eye syndrome. Dry eye syndrome is a common issue arising when tears fail to adequately lubricate the eyes, often due to insufficiency and instability. Various products, such as liquid drops, gel, liquid wipes, and eye ointment, are utilized and can be found in hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies.

The dry eye medication market research report is one of a series of new reports from The Business Research Company that provides dry eye medication market statistics, including dry eye medication industry global market size, regional shares, competitors with a dry eye medication market share, detailed dry eye medication market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye medication industry. This dry eye medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry eye medication market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $10.93 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The expansion observed in the past can be linked to factors such as an aging population, a growing number of contact lens users, an increase in disposable income, a rise in the availability of treatment options, a surge in the prevalence of allergies, an uptick in the consumption of unhealthy or improper diets, and the prevalence of diabetes mellitus.

The dry eye medication market size is expected to see rapid growth in the next few years. It will grow to $16.93 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The anticipated growth in the upcoming period can be ascribed to factors such as the increasing prevalence of laser surgeries, elevated screen time, busy lifestyles, a growing burden of diabetes, a rise in the prevalence of dry eye disease, a promising pipeline for dry eye disease, and the side effects associated with other medications. Key trends expected in the forecast period involve the creation of preservative-free eye drops, investment in the research and development of new and advanced drugs, the innovation of drugs to remain competitive in the market, the development of non-steroidal anti-inflammatory ophthalmic drugs for treating dry-eye syndrome, a focus on integrating modern techniques, and the development of combination therapies for the treatment of dry eye diseases.

The growing incidence of dry eye disease is contributing to an increased demand for its treatment. Factors such as aging, vitamin A deficiency, contact lens usage, eye surgeries, exposure to dry wind or smoke, and prolonged screen time are identified as factors that make individuals more susceptible to dry eye. For instance, a survey by the American Academy of Ophthalmology revealed that in the USA, nearly 3.2 million women and 1.68 million men aged over 50 were affected by dry eye syndrome. Similarly, a study from the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in Northern India. The escalating prevalence of the disease is expected to drive the demand for its treatment and consequently foster the growth of the dry eye medication market.

The increasing number of ocular surgery procedures is anticipated to propel the expansion of the dry eye medication market. Ocular surgery, focusing on the diagnosis, treatment, and surgical management of various eye conditions and diseases, requires dry eye medication to ensure the eye's surface remains lubricated and comfortable. This facilitates smoother surgical procedures and aids in post-operative recovery. For instance, in October 2023, the Organization for Economic Co-operation and Development reported an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Hence, the upward trend in ocular surgery procedures is a driving force behind the growth of the dry eye medication market.

The treatment landscape for dry eye disease has advanced through the incorporation of modern techniques, leading to the development of advanced hyaluronic acid-based lubricants and lipid emulsions. These innovations have replaced traditional artificial tears containing isotonic sodium chloride, offering prolonged lubrication on the eye's surface. For example, Allergan, a global pharmaceutical company, introduced Refresh Repair Lubricant Eye Drops designed to repair and protect against dry eye disease, enhance vision clarity, and formulated with carboxymethylcellulose (CMC), hyaluronic acid, and osmoprotectants. These components contribute to ocular surface health and epithelial cell protection. Technological advancements are poised to positively impact the dry eye medication market.

Key players in the hormonal replacement therapy drugs market are strategically focusing on introducing single-ingredient prescription eye drops such as Miebo to optimize market revenue. Miebo is a prescription eye drop specifically designed for treating the signs and symptoms of dry eye disease. For instance, in September 2023, Bausch + Lomb, a US-based eye health company, launched Miebo in the United States, targeting tear evaporation-the primary cause of dry eye disease. Miebo is a water-free, preservative-free, and steroid-free single-ingredient prescription eye drop that quickly and comfortably spreads, reducing tear evaporation at the ocular surface.

In July 2022, Alcon, a Switzerland-based ophthalmology company, acquired Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals for $60 million. This strategic move enhances Alcon's portfolio by adding Inveltys, a treatment for post-operative inflammation and pain following ocular surgery. Kala Pharmaceuticals, a US-based pharmaceutical company specializing in ocular medications, facilitated this acquisition.

Major companies operating in the dry eye medication market report are Allergan PLC, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Shanghai Pharmaceutical, ERC Labs, Vision gain, Medicom Health care, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Endo International PLC, Aurinia Pharmaceuticals Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc., shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Bausch & Lomb Incorporated, Azura Ophthamics Ltd., Similasan, Hoya Corporation, Adcock Ingram.

North America was the largest region in the dry eye medication market in 2023. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dry eye medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The dry eye medication market consists of sales of polyethylene glycol, polyvinyl alcohol, propylene glycol, carboxymethylcellulose, povidone, glycerine, and mineral oil. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Eye Medication Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry eye medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry eye medication? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry eye medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Silica Gel; Zeolite; Activated Alumina; Activated Charcoal; Calcium Chloride; Clay; Other Types
  • 2) By Process: Physical Absorption; Chemical Absorption
  • 3) By Application: Electronics; Food; Pharmaceutical; Packing; Other Applications
  • Companies Mentioned: Allergan plc; Alcon Inc.; Bausch Health Companies Inc.; Novartis AG; Otsuka Holdings Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Eye Medication Market Characteristics

3. Dry Eye Medication Market Trends And Strategies

4. Dry Eye Medication Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Dry Eye Medication Market Size and Growth

  • 5.1. Global Dry Eye Medication Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Dry Eye Medication Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Dry Eye Medication Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dry Eye Medication Market Segmentation

  • 6.1. Global Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Aqueous
  • Evaporative
  • Aqueous and Evaporative
  • 6.2. Global Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liquid
  • Gel
  • Ointment
  • Other Delivery Systems
  • 6.3. Global Dry Eye Medication Market, Segmentation By Prescription Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • OTC Drugs
  • Prescription Drugs
  • 6.4. Global Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Eye Health Clinics
  • Retail Pharmacies
  • Online Pharmacies

7. Dry Eye Medication Market Regional And Country Analysis

  • 7.1. Global Dry Eye Medication Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Dry Eye Medication Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dry Eye Medication Market

  • 8.1. Asia-Pacific Dry Eye Medication Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dry Eye Medication Market

  • 9.1. China Dry Eye Medication Market Overview
  • 9.2. China Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dry Eye Medication Market

  • 10.1. India Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dry Eye Medication Market

  • 11.1. Japan Dry Eye Medication Market Overview
  • 11.2. Japan Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dry Eye Medication Market

  • 12.1. Australia Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dry Eye Medication Market

  • 13.1. Indonesia Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dry Eye Medication Market

  • 14.1. South Korea Dry Eye Medication Market Overview
  • 14.2. South Korea Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dry Eye Medication Market

  • 15.1. Western Europe Dry Eye Medication Market Overview
  • 15.2. Western Europe Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dry Eye Medication Market

  • 16.1. UK Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dry Eye Medication Market

  • 17.1. Germany Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dry Eye Medication Market

  • 18.1. France Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dry Eye Medication Market

  • 19.1. Italy Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dry Eye Medication Market

  • 20.1. Spain Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dry Eye Medication Market

  • 21.1. Eastern Europe Dry Eye Medication Market Overview
  • 21.2. Eastern Europe Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dry Eye Medication Market

  • 22.1. Russia Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dry Eye Medication Market

  • 23.1. North America Dry Eye Medication Market Overview
  • 23.2. North America Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dry Eye Medication Market

  • 24.1. USA Dry Eye Medication Market Overview
  • 24.2. USA Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dry Eye Medication Market

  • 25.1. Canada Dry Eye Medication Market Overview
  • 25.2. Canada Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dry Eye Medication Market

  • 26.1. South America Dry Eye Medication Market Overview
  • 26.2. South America Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dry Eye Medication Market

  • 27.1. Brazil Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dry Eye Medication Market

  • 28.1. Middle East Dry Eye Medication Market Overview
  • 28.2. Middle East Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dry Eye Medication Market

  • 29.1. Africa Dry Eye Medication Market Overview
  • 29.2. Africa Dry Eye Medication Market, Segmentation By Type of Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Dry Eye Medication Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dry Eye Medication Market Competitive Landscape And Company Profiles

  • 30.1. Dry Eye Medication Market Competitive Landscape
  • 30.2. Dry Eye Medication Market Company Profiles
    • 30.2.1. Allergan plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Alcon Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bausch Health Companies Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Otsuka Holdings Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Dry Eye Medication Market Other Major And Innovative Companies

  • 31.1. Santen Pharmaceutical Co., Ltd.
  • 31.2. Sentiss Pharma Pvt. Ltd.
  • 31.3. OASIS Medical, Inc.
  • 31.4. VISUfarma B.V.
  • 31.5. Sun Pharmaceutical Industries Limited
  • 31.6. Bayer AG
  • 31.7. Pfizer
  • 31.8. Johnson & Johnson
  • 31.9. Daiichi Sankyo
  • 31.10. Zhaoke Ophthalmology Pharmaceutical
  • 31.11. Shanghai Pharmaceutical
  • 31.12. ERC Labs
  • 31.13. Vision gain
  • 31.14. Medicom Health care
  • 31.15. Implandata ophthalmic products GmbH

32. Global Dry Eye Medication Market Competitive Benchmarking

33. Global Dry Eye Medication Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Dry Eye Medication Market

35. Dry Eye Medication Market Future Outlook and Potential Analysis

  • 35.1 Dry Eye Medication Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Dry Eye Medication Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Dry Eye Medication Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제